What exactly did Morgan Stanley change on Feb 20, 2026 for Sempra?

Morgan Stanley maintained **Overweight** on Sempra and raised the price target to **$101** from **$97** on Feb 20, 2026. The firm kept a positive stance while nudging expected upside higher, per TheFly [source](https://thefly.com/permalinks/entry.php/id4297564/1161286394/SRE-Sempra-Energy-pricearget

How should investors interpret the SRE analyst rating 'Overweight'?

An **Overweight** rating means the analyst expects Sempra to outperform peers. It signals relative strength versus the sector, not an absolute buy for every investor. Use it with dividend, valuation, and regulatory considerations.

Does the new SRE price target change dividend expectations?

A raised price target to **$101** mainly reflects expected share appreciation, not a direct dividend change. Dividend plans depend on company cash flow and board policy, though a stronger outlook can support future payouts.

Where can I see recent analyst moves and consensus for SRE?

Recent analyst actions, including maintains by Barclays and Morgan Stanley, are tracked on MarketWatch’s analyst estimates page for SRE [source](https://www.marketwatch.com/investing/stock/sre/analystestimates). Use consensus data with company reports and regulatory news.

Analyst Ratings

Morgan Stanley Maintains Overweight on Sempra (SRE) Feb 20 2026 PT $101

ByDanny Kontos February 23, 2026

On Feb 20, 2026 Morgan Stanley maintained an Overweight rating on Sempra (SRE) and raised its price target to $101 from $97, a signal the firm still expects outperformance. The SRE analyst rating update keeps Sempra in a favored spot among utility names, while the modest intraday move of 0.04% ($0.04) shows limited immediate market reaction. Investors should note the rating was maintained rather than upgraded, keeping the firm’s positive stance but not changing conviction.